Loading...
Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors
Oncogene-addicted cancers are predominantly driven by specific oncogenic pathways and display initial exquisite sensitivity to designer therapies, but eventually become refractory to treatments. Clear understanding of lung tumorigenic mechanisms is essential for improved therapies. Methods: Lysosome...
Na minha lista:
| Udgivet i: | Theranostics |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ivyspring International Publisher
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7052910/ https://ncbi.nlm.nih.gov/pubmed/32194831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.38729 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|